212 related articles for article (PubMed ID: 31586988)
1. Systematic profiling of alternative splicing events and splicing factors in left- and right-sided colon cancer.
Huang X; Liu J; Mo X; Liu H; Wei C; Huang L; Chen J; Tian C; Meng Y; Wu G; Xie W; P C FJ; Liu Z; Tang W
Aging (Albany NY); 2019 Oct; 11(19):8270-8293. PubMed ID: 31586988
[TBL] [Abstract][Full Text] [Related]
2. Weighted gene co-expression network analysis identifies the prognosis-related models of left- and right-sided colon cancer.
Long C; Li G; Meng Y; Huang X; Chen J; Liu J
Medicine (Baltimore); 2023 May; 102(18):e33390. PubMed ID: 37144998
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
[TBL] [Abstract][Full Text] [Related]
5. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
[TBL] [Abstract][Full Text] [Related]
6. Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
Zhao J; Chang L; Gu X; Liu J; Sun B; Wei X
Cancer Sci; 2020 Aug; 111(8):3020-3031. PubMed ID: 32530556
[TBL] [Abstract][Full Text] [Related]
7. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
[TBL] [Abstract][Full Text] [Related]
8. Characterization of alternative splicing events and prognostic signatures in breast cancer.
Han P; Zhu J; Feng G; Wang Z; Ding Y
BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
10. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
Wan Q; Sang X; Jin L; Wang Z
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
[TBL] [Abstract][Full Text] [Related]
11. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
12. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of clinicopathological features and prognosis between left-sided colon cancer and right-sided colon cancer].
Gao X; Yu G; Liu P; Hao L; Liu L; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):647-653. PubMed ID: 28643309
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression.
Feng H; Jin Z; Liu K; Peng Y; Jiang S; Wang C; Hu J; Shen X; Qiu W; Cheng X; Zhao R
J Cell Mol Med; 2020 Nov; 24(21):12667-12680. PubMed ID: 32939931
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
Duan Y; Zhang D
J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370
[TBL] [Abstract][Full Text] [Related]
16. Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer.
Zhu J; Chen Z; Yong L
Gynecol Oncol; 2018 Feb; 148(2):368-374. PubMed ID: 29191436
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer.
Li X; Wang Y; Li B; Ma W
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32079071
[TBL] [Abstract][Full Text] [Related]
18. Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing.
Gong S; Song Z; Spezia-Lindner D; Meng F; Ruan T; Ying G; Lai C; Wu Q; Liang Y
Front Genet; 2020; 11():534. PubMed ID: 32595697
[TBL] [Abstract][Full Text] [Related]
19. Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer.
Hu YX; Zheng MJ; Zhang WC; Li X; Gou R; Nie X; Liu Q; Hao YY; Liu JJ; Lin B
J Transl Med; 2019 Nov; 17(1):379. PubMed ID: 31744495
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis reveals the prognostic value and functions of splicing factors implicated in hepatocellular carcinoma.
Wang Y; Yang F; Shang J; He H; Yang Q
Sci Rep; 2021 Jul; 11(1):15175. PubMed ID: 34312475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]